Literature DB >> 35129497

Development and Validation of an Electronic Health Record-based Score for Triage to Perioperative Medicine.

Sidney T Le1, Dalton Corbin, Laura C Myers, Patricia Kipnis, Bradley Cohn, Vincent X Liu.   

Abstract

OBJECTIVE: To develop an electronic health record-based risk model for perioperative medicine (POM) triage and compare this model with legacy triage practices that were based on clinician assessment. SUMMARY OF BACKGROUND DATA: POM clinicians seek to address the increasingly complex medical needs of patients prior to scheduled surgery. Identifying which patients might derive the most benefit from evaluation is challenging.
METHODS: Elective surgical cases performed within a health system 2014-2019 (N = 470,727) were used to develop a predictive score, called the Comorbidity Assessment for Surgical Triage (CAST) score, using split validation. CAST incorporates patient and surgical case characteristics to predict the risk of 30-day post-operative morbidity, defined as a composite of mortality and major NSQIP complications. Thresholds of CAST were then selected to define risk groups, which correspond with triage to POM appointments of different durations and modalities. The predictive discrimination CAST score was compared with the surgeon's assessments of patient complexity and the American Society of Anesthesiologists class.
RESULTS: The CAST score demonstrated a significantly higher discrimination for predicting post-operative morbidity (area under the receiver operating characteristic curve 0.75) than the surgeon's complexity designation (0.63; P < 0.001) or the American Society of Anesthesiologists (0.65; P < 0.001) (Fig. 1). Incorporating the complexity designation in the CAST model did not significantly alter the discrimination (0.75; P = 0.098). Compared with the complexity designation, classification based on CAST score groups resulted a net reclassification improvement index of 10.4% (P < 0.001) (Table 1).
CONCLUSION: A parsimonious electronic health record-based predictive model demonstrates improved performance for identifying pre-surgical patients who are at risk than previously-used assessments for POM triage.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 35129497     DOI: 10.1097/SLA.0000000000005284

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study.

Authors:  Shuai Xu; Xiu-Ping Zhang; Guo-Dong Zhao; Wen-Bo Zou; Zhi-Ming Zhao; Ming-Gen Hu; Yuan-Xing Gao; Xiang-Long Tan; Qu Liu; Rong Liu
Journal:  Surg Endosc       Date:  2022-05-09       Impact factor: 4.584

2.  Short- and long-term outcomes after robotic and open liver resection for elderly patients with hepatocellular carcinoma: a propensity score-matched study.

Authors:  Xiu-Ping Zhang; Shuai Xu; Ming-Gen Hu; Zhi-Ming Zhao; Zhao-Hai Wang; Guo-Dong Zhao; Cheng-Gang Li; Xiang-Long Tan; Rong Liu
Journal:  Surg Endosc       Date:  2022-05-09       Impact factor: 4.584

Review 3.  [Surgical treatment of pancreatic cancer-What is new?]

Authors:  Thomas Schmidt; Orlin Belyaev; Waldemar Uhl; Christiane J Bruns
Journal:  Chirurg       Date:  2022-03-31       Impact factor: 0.955

4.  Pancreaticoduodenectomy for benign and premalignant pancreatic and ampullary disease: is robotic surgery the better approach?

Authors:  Benedetto Mungo; Abdulrahman Hammad; Samer AlMasri; Epameinondas Dogeas; Ibrahim Nassour; Aatur D Singhi; Herbert J Zeh; Melissa E Hogg; Kenneth K W Lee; Amer H Zureikat; Alessandro Paniccia
Journal:  Surg Endosc       Date:  2022-09-22       Impact factor: 3.453

5.  Comparison of Electronic Frailty Metrics for Prediction of Adverse Outcomes of Abdominal Surgery.

Authors:  Sidney T Le; Vincent X Liu; Patricia Kipnis; Jie Zhang; Peter D Peng; Elizabeth M Cespedes Feliciano
Journal:  JAMA Surg       Date:  2022-05-11       Impact factor: 16.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.